An easy-to-use self-test paired with an intuitive mobile app to deliver accurate results in just 10 minutes.
Our AI-powered platform seamlessly integrates with On/Go rapid tests, offering a real-time solution to avoid costly shutdowns through rapid, targeted interventions. To support the fight against COVID-19, our portal provides:
We are excited to offer a smarter COVID solution that enables healthier, happier citizens, an open economy and enhanced peace of mind.
On/Go and On/Go One tests are over-the-counter, self-administered rapid antigen tests that deliver results in just minutes. Both tests can be used to detect the antigen proteins from all major known COVID-19 variants of concern.
The On/Go™ COVID-19 Antigen Self-Test and On/Go One COVID Home Test are an over-the-counter, self-performed rapid test for the detection of SARS-CoV-2. The tests are authorized for non-prescription home use by individuals aged 14 years or older or adult collected from individuals aged 2 years or older. On/Go tests are best taken by using the top- rated On/Go app, which provides clear, step-by-step instructions for specimen collection and result interpretation.
The On/Go and On/Go One tests have not been FDA cleared or approved but have been authorized by FDA under an Emergency Use Authorization (EUA). These products have been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; the tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
The On/Go COVID-19 Antigen Self Test and the On/Go One COVID-19 Antigen Home Tests are lateral flow chromatographic immunoassays intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19
